Sixth Edition of Aon’s Life Sciences Clinical Trials Risk Map

Let Aon support you in this essential step of the regulatory approval process.

The globalization of clinical trials continues to rise, leading to a plethora of regulatory and operational challenges for the Life Sciences industry. Aon's latest Clinical Trials Risk Map provides an overview of the global clinical trials risk landscape in more than 80 countries, highlighting potential challenges for life sciences companies that conduct global clinical trials.

Key Highlights:

• The Life Sciences industry continues to look outside of the U.S. to conduct clinical trials in order to advance their products through the regulatory approval process
• Each country has specific clinical trials liability insurance requirements that trial sponsors must comply with in order to commence a clinical trial
• In most countries, local admitted certificates of insurance with specific requirements are usually required for regulatory filings prior to trial approval

 

*If you have any questions about your specific coverage, or are interested in obtaining coverage, please contact your Aon broker.